University of California, Las Angeles Medical Center — Los Angeles, California

University of California, Las Angeles Medical Center is a clinical research site located in Los Angeles, California, United States 90027.

Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, Las Angeles Medical Center has participated in 1 clinical trials.

Therapeutic areas: Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma.

Sponsors: Samus Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, Las Angeles Medical Center?

University of California, Las Angeles Medical Center has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, Las Angeles Medical Center conducted?

University of California, Las Angeles Medical Center has 1 clinical trials on record. Their work covers Recurrent Glioblastoma Multiforme (GBM), Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma, Grade 3 or 4 Astrocytoma.

Is University of California, Las Angeles Medical Center accredited by Crixeo Health?

University of California, Las Angeles Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, Las Angeles Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.